On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Norbert Vey

ResearcherPublications, citations & collaboration network

Norbert Vey is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Norbert Vey have?

ScholarIQindexed works

Norbert Vey has 910 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Norbert Vey have?

ScholarIQcitation count

Norbert Vey has 24,945 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Norbert Vey?

ScholarIQh-index

Norbert Vey has an h-index of 79 in OpenAlex.

What is the i10-index of Norbert Vey?

ScholarIQi10-index

Norbert Vey has an i10-index of 350 in OpenAlex.

What is the ORCID of Norbert Vey?

ScholarIQorcid

The ORCID for Norbert Vey is on the source record.

What is the OpenAlex record for Norbert Vey?

ScholarIQopenalex

The OpenAlex for Norbert Vey is on the source record.

What are the most-cited papers on Norbert Vey?

ScholarIQmost cited works
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani, John E. Godwin, Martha Arellano, Kendra Sweet, Ashkan Emadi, Farhad Ravandi, Harry P. Erba, Michael Byrne, Laura C. Michaelis, Max S. Topp, Norbert Vey, Fabio Ciceri, Matteo Giovanni Carrabba, Stefania Paolini, Gerwin Huls, Mojca Jongen‐Lavrencic, Martin Wermke, Patrice Chevallier, Emmanuel Gyan, Christian Récher, Patrick J. Stiff, Kristen Pettit, Bob Löwenberg, S. Church, Erica Anderson, Jayakumar Vadakekolathu, Marianne Santaguida, Michael P. Rettig, John Muth, Teia Curtis, Erin Fehr, Kuo Guo, Jian Zhao, Ouiam Bakkacha, Kenneth Jacobs, Kathy Tran, Patrick Kaminker, Maya Kostova, Ezio Bonvini, Roland B. Walter, Jan Davidson‐Moncada, Sergio Rutella, John F. DiPersio
Blood. 2020323 CitationsOPEN ACCESS
Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents
Valeria Santini, António Almeida, Aristoteles Giagounidis, Stefanie Gröpper, Anna Jonášová, Norbert Vey, Ghulam J. Mufti, Rena Buckstein, Moshe Mittelman, Uwe Platzbecker, Ofer Shpilberg, Ron Ram, Consuelo del Cañizo, Norbert Gattermann, Keiya Ozawa, Alberto Risueño, Kyle J. MacBeth, Jianhua Zhong, Francis Séguy, Albert Hoenekopp, C.L. Beach, Pierre Fenaux
Journal of Clinical Oncology. 2016215 Citations

Related on ScholarIQ

470M+ articles · free account